¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

¾ç»êºÎ»ê´ëÇб³º´¿ø ¼Ò¾Æû¼Ò³â°ú ±¹°¡¹ÙÀÌ¿À ºòµ¥ÀÌÅÍ ±¸Ãà ½Ã¹ü»ç¾÷ ½ÉÆ÷Áö¿ò : 2022-03-05

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
¾ç»êºÎ»ê´ëÇб³º´¿ø ¼Ò¾Æû¼Ò³â°ú ±¹°¡¹ÙÀÌ¿À ºòµ¥ÀÌÅÍ ±¸Ãà ½Ã¹ü»ç¾÷ ½ÉÆ÷Áö¿ò : 2022-03-05
±³À°ÀÏÀÚ : 2022-03-05
±³À°Àå¼Ò : ºÎ»ê ÆÄÅ©ÇϾæƮȣÅÚ 2Ãþ º¼·ë  
±³À°ÁÖÁ¦ : ±¹°¡¹ÙÀÌ¿À ºòµ¥ÀÌÅÍ ±¸Ãà ½Ã¹ü»ç¾÷ ½ÉÆ÷Áö¿ò
ÁÖÃÖ±â°ü : ¾ç»êºÎ»ê´ëÇб³º´¿ø
½ÃÇà±â°ü(ÁöºÎ/°ú) : ¼Ò¾Æû¼Ò³â°ú  
´ã´çÀÚ : ¼ºÇöÁÖ
¿¬¶ôó : 055-360-3728  
À̸ÞÀÏ : shj192@naver.com      
±³À°Á¾·ù : ¼Ò¾Æû¼Ò³â°úÀÇ»çÇÐ, ºÐÀÚ»ý¹°ÇÐ
Âü¼®¿¹»óÀοø : 50¸í
Èñ¸ÁÆòÁ¡ : 4Á¡  
Áö¿ª : ºÎ»ê±¤¿ª½Ã
±³À°½Ã°£ : 4 ½Ã°£ 30ºÐ  
¼¼ºÎ¼ö°­·á : 0¿ø      
ºñ°í       

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 03-05 ºÎ»ê ÆÄÅ©ÇϾæƮȣÅÚ 2Ãþ º¼·ë 10:00~10:30 µî·Ï  () 
±âŸ 03-05 ºÎ»ê ÆÄÅ©ÇϾæƮȣÅÚ 2Ãþ º¼·ë 10:30~10:35 Ãà»ç  ±èÀçÈ£(¾ç»êºÎ»ê´ëÇб³º´¿ø) 
±âŸ 03-05 ºÎ»ê ÆÄÅ©ÇϾæƮȣÅÚ 2Ãþ º¼·ë 10:35~10:40 °³È¸»ç  ÀüÁ¾±Ù(¾ç»êºÎ»ê´ëÇб³º´¿ø) 
±³À°½Ã°£ 03-05 ºÎ»ê ÆÄÅ©ÇϾæƮȣÅÚ 2Ãþ º¼·ë 10:40~11:10 ±¹°¡¹ÙÀÌ¿Àºòµ¥ÀÌÅÍ ½Ã¹ü»ç¾÷ ¼º°ú¿Í °úÁ¦  ¹ÚÇö¿µ(Áúº´°ü¸®Ã») 
±³À°½Ã°£ 03-05 ºÎ»ê ÆÄÅ©ÇϾæƮȣÅÚ 2Ãþ º¼·ë 11:10~11:40 Missense Variant in RHOBTB2 causing a developmental and epileptic encephalopathy  À¯¼®µ¿(ºÎ»êÀÇ´ë) 
±³À°½Ã°£ 03-05 ºÎ»ê ÆÄÅ©ÇϾæƮȣÅÚ 2Ãþ º¼·ë 11:40~12:10 HNRNPU related disorder  ±è¼öÁø(ÀÎÇÏÀÇ´ë) 
±³À°½Ã°£ 03-05 ºÎ»ê ÆÄÅ©ÇϾæƮȣÅÚ 2Ãþ º¼·ë 12:10~12:40 Cornelia de Lange syndrome  ÀÓÇÑÇõ(Ãæ³²ÀÇ´ë) 
½Ä»ç 03-05 ºÎ»ê ÆÄÅ©ÇϾæƮȣÅÚ 2Ãþ º¼·ë 12:40~13:30 Á¡½É  () 
±³À°½Ã°£ 03-05 ºÎ»ê ÆÄÅ©ÇϾæƮȣÅÚ 2Ãþ º¼·ë 13:30~14:00 JUP mutation in adult onset familial cardiomyopathy  È²¼öÁø(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 03-05 ºÎ»ê ÆÄÅ©ÇϾæƮȣÅÚ 2Ãþ º¼·ë 14:00~14:30 Warburg-Cinotti Syndrome  ÀÌÀ±Á¤(°æºÏÀÇ´ë) 
±³À°½Ã°£ 03-05 ºÎ»ê ÆÄÅ©ÇϾæƮȣÅÚ 2Ãþ º¼·ë 14:30~15:00 The Experience of The National Pilot Project of Bio Big Data Construction in View of Adult Undiagnosed Diseases  ±è¸¸Áø(¼­¿ïÀÇ´ë) 
È޽Ġ03-05 ºÎ»ê ÆÄÅ©ÇϾæƮȣÅÚ 2Ãþ º¼·ë 15:00~15:20 È޽Ġ () 
±³À°½Ã°£ 03-05 ºÎ»ê ÆÄÅ©ÇϾæƮȣÅÚ 2Ãþ º¼·ë 15:20~15:50 Genome analysis pipeline in the Pilot Korean Genome Project  ±è¼±¿µ(±¹°¡»ý¸í¿¬±¸ÀÚ¿øÁ¤º¸¼¾ÅÍ) 
±³À°½Ã°£ 03-05 ºÎ»ê ÆÄÅ©ÇϾæƮȣÅÚ 2Ãþ º¼·ë 15:50~16:20 Research environment platform for biomedical research using bio-big data  °­È¿Áø(Çѱ¹°úÇбâ¼úÁ¤º¸¿¬±¸¿ø) 
±âŸ 03-05 ºÎ»ê ÆÄÅ©ÇϾæƮȣÅÚ 2Ãþ º¼·ë 16:20~16:30 Æóȸ  () 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ¾ç»êºÎ»ê´ëÇб³º´¿ø ¼Ò¾Æû¼Ò³â°ú ±¹°¡¹ÙÀÌ¿À ºòµ¥ÀÌÅÍ ±¸Ãà ½Ã¹ü»ç¾÷ ½ÉÆ÷Áö¿ò : 2022-03-05""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û (¿Â¶óÀÎ)ÀÌ´ë¸ñµ¿º´¿ø »êºÎÀΰú Áö¿ªÀÇ»ç °£´ãȸ : 2022-03-05
´ÙÀ½±Û ´ëÇÑ°ß¡¤ÁÖ°üÀýÇÐȸ °æ»óÁöȸ Shoulder Camp : 2022-03-05
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
9 °æ±â ¸íÁöº´¿ø ¿äÃò ¹× ½½°üÀý ÅëÁõ Ä¡·áÀÇ ÃÖ½ÅÁö°ß : 2018-07-28 0 1,056 2018-07-28
8 ¼­¿ï 2018³âµµ ´ëÇÑÅëÁõÇÐȸ Á¦3Â÷ CADAVER WORKSHOP : 2018-07-28 0 1,009 2018-07-28
7 ¼­¿ï ´ëÇÑÁ¾¾ç¿Ü°úÇÐȸ 2018³â ´ëÇÑÁ¾¾ç¿Ü°úÇÐȸ ¿¬¼ö°­Á : 2018-07-28 0 942 2018-07-28
6 °æ±â ´ëÇѳ»½Ã°æº¹°­°æ¿Ü°úÇÐȸ 2018 Pressurized Intra Peritoneal Aerosol Chemotherapy (PIPAC) Symposium : 2018-07-28 0 1,187 2018-07-28
5 ¼­¿ï °­³²¼¼ºê¶õ½ºº´¿ø Hyperhidrosis Symposium : 2018-07-28 0 1,467 2018-07-28
4 ¼­¿ï °¡Å縯´ëÇб³¿©Àǵµ¼º¸ðº´¿ø 2018 The 11th Catholic Neurosurgery Update Symposium : 2018-07-28 0 1,346 2018-07-28
3 °æ±â ´ëÇÑ´ç´¢º´ÇÐȸ °æÀÎÁöȸEGDM (Essential Guideline to Diabetes Management) : 2018-07-28 0 2,135 2018-07-28
2 ¼­¿ï ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ 2018³âµµ ¡ººÐ¼®½É¸®ÇÐ ±âÃÊ°­Á¡»: 2018-07-28 0 1,395 2018-07-28
1 ¼­¿ï °­³²¼¼ºê¶õ½ºº´¿ø ¼ºÇü¿Ü°ú °­³² Áý´ãȸ : 2018-07-28 0 1,916 2018-07-28
1371 | 1372 | 1373 | 1374 | 1375 | 1376 | 1377 | 1378 | 1379 | 1380
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷